Poseida Therapeutics, Inc.
CHIMERIC ANTIGEN RECEPTORS (CARS) SPECIFIC FOR MUC1 AND METHODS FOR THEIR USE

Abstract:

Disclosed are MUC1-CAR compositions and methods for use of these compositions to target a MUC1 protein, including CARTyrin compositions, wherein the cell expressing the targeted MUC1 protein may be targeted and killed by, for instance, a cytotoxic T cell.